NVAX NOVAVAX INC Disposals and divestitures 8-K Filing 2024 - Asset Sale Novavax Inc. has entered into an agreement to sell its biologics manufacturing campus in Czech Republic to Novo Nordisk for $200 million, with an initial payment of $10 million already made. The deal includes the transfer of assets, contracts, and employees, and is subject to regulatory approval.Get access to all SEC 8-K filings of the NOVAVAX INC